Miramar Capital, LLC Abb Vie Inc. Transaction History

Miramar Capital, LLC

$400 Million
Q2 2024

A detailed history of Miramar Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Miramar Capital, LLC holds 102,841 shares of ABBV stock, worth $20.6 Million. This represents 4.41% of its overall portfolio holdings.

Number of Shares

102,841

Previous 102,077 0.75%

Holding current value

$20.6 Million

Previous $18.6 Million 5.11%

% of portfolio

4.41%

Previous 4.57%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $118,259 - $138,100	764 Added 0.75%	102,841 $17.6 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $194,980 - $222,162	-1,220 Reduced 1.18%	102,077 $18.6 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $800,006 - $900,995	-5,814 Reduced 5.33%	103,297 $16 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $557,604 - $645,509	-4,174 Reduced 3.68%	109,111 $16.3 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $133,305 - $165,889	-1,006 Reduced 0.88%	113,285 $15.3 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $113,374 - $130,567	784 Added 0.69%	114,291 $18.2 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $1,936 - $2,322	14 Added 0.01%	113,507 $18.4 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $733,055 - $840,765	5,462 Added 5.06%	113,493 $16.8 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $530,937 - $674,995	3,858 Added 3.7%	108,031 $16.5 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $1.72 Million - $2.13 Million	13,003 Added 14.26%	104,173 $16.9 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $269,971 - $341,592	2,513 Added 2.83%	91,170 $12.3 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $578,390 - $656,560	5,436 Added 6.53%	88,657 $9.56 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $165,179 - $184,019	1,570 Added 1.92%	83,221 $9.58 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $45,421 - $50,003	-444 Reduced 0.54%	81,651 $8.84 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $1.36 Million - $1.84 Million	16,952 Added 26.02%	82,095 $8.77 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $89,775 - $105,367	1,045 Added 1.63%	65,143 $5.75 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $156,498 - $209,417	2,133 Added 3.44%	64,098 $6.04 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $79,335 - $120,281	1,230 Added 2.03%	61,965 $4.72 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $400,321 - $500,887	5,550 Added 10.06%	60,735 $5.12 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $75,072 - $90,258	1,192 Added 2.21%	55,185 $4.27 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $855,611 - $1.09 Million	13,023 Added 31.79%	53,993 $3.6 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $7,328 - $8,625	95 Added 0.23%	40,970 $3.3 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $3.18 Million - $3.92 Million	40,875 New	40,875 $3.27 Million

Others Institutions Holding ABBV

# of Institutions

3,773

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $354B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Account

Miramar Capital, LLC Abb Vie Inc. Transaction History